000766.SZ
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 14.80
+1.58%Year over year
Reported trailing growth
- Revenue
- -11.7%
- EBITDA
- —
- EBIT
- -45.1%
- EPS
- -40.2%
- Free cash flow
- -74.5%
- Operating cash flow
- -51.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -7.3%
- EBITDA
- -5.1%
- EBIT
- -5.5%
- Net income
- +4.4%
- EPS
- +10.1%
- Free cash flow
- -38.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026